{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-350898","form_type":"8-K","ticker":"CORT","cik":"0001088856","company_name":"CORCEPT THERAPEUTICS INC","filed_at":"2021-12-08T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.441583+00:00","generated_at":"2026-06-28T02:43:19.194504+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Corcept wins patent appeal, discloses DOJ subpoena on Korlym sales, extends tender offer to Dec 15","bullets":["Federal Circuit affirmed PTAB decision upholding validity of '214 patent (expires 2037) against Teva challenge.","Received HIPAA subpoena from NJ USAO regarding Korlym sales and HCP payments; investigating potential criminal/civil violations; Corcept not a defendant.","Extended tender offer expiration to Dec 15, 2021; 8,282,336 shares tendered to date; condition of at least 3M shares tendered."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-350898","json":"https://secwatch.observer/filing/0001193125-21-350898.json","markdown":"https://secwatch.observer/filing/0001193125-21-350898.md","text":"https://secwatch.observer/filing/0001193125-21-350898.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1088856/000119312521350898/0001193125-21-350898-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1088856/000119312521350898/d255329d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T02:43:19.194504+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}